Toggle navigation
Home
Search
Services
Blog
Contact
About
Atherogenic & Antiatherogenic Lipoproteins in Cad
Wilson, Paul R.
Oklahoma Medical Research Foundation, Oklahoma City, OK, United States
Search 36 grants from Paul Wilson
Search grants from Oklahoma Medical Research Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
GH15-1632, Cameroon: GLOBAL HEALTH SECURITY PARTNER ENGAGEMENT FOR CAMEROON AND NIGERIA
Activation of TRPA1 Irritant Receptors by Acrolein and Fungal Toxicants
UC Berkeley Prevention Research Center
Improv.the Hth, Ed.,and Well-Being of Young Peop. Thru Coord.Sch.Hth Pgms
Exceptional Financial Need Scholarship
Recently added grants:
Designer covalent heterobivalent inhibitors to prevent IgE-dependent allergic reactions
Outer Membrane Vesicles (OMVs) and Proteomics
Host Response Monitoring
Functional Antibody Study
Mouse Immunization/Challenge
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32HL008004-01A1
Application #
3051129
Study Section
Clinical Sciences Subcommittee 1 (CLN)
Project Start
1989-10-09
Project End
Budget Start
1989-05-01
Budget End
1990-04-30
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Institution
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Related projects
NIH 1990
F32 HL
Atherogenic & Antiatherogenic Lipoproteins in Cad
Wilson, Paul R. / Oklahoma Medical Research Foundation
NIH 1989
F32 HL
Atherogenic & Antiatherogenic Lipoproteins in Cad
Wilson, Paul R. / Oklahoma Medical Research Foundation
Comments
Be the first to comment on Paul Wilson's grant